Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX2 | P34913 | 5/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.50 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.46 |
| ▸ | PPARG | P37231 | 6/20 | 0.46 |
| ▸ | PPARD | Q03181 | 6/20 | 0.46 |
| ▸ | PPARA | Q07869 | 6/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.46 |
| ▸ | TSHR | P16473 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | TLR2 | O60603 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.46 |
| ▸ | FABP4 | P15090 | 2/20 | 0.46 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.46 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.46 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6472585 | 1.00 | EPHX2 (0.51) | EPHX2DNM1GPR84PPARGPPARD | |
| SCHEMBL4874900 | 1.00 | EPHX2 (0.51) | EPHX2DNM1GPR84PPARGPPARD | |
| SCHEMBL6751324 | 1.00 | EPHX2 (0.51) | EPHX2DNM1GPR84PPARGPPARD | |
| SCHEMBL28553323 | 1.00 | EPHX2 (0.51) | EPHX2DNM1GPR84PPARGPPARD | |
| SCHEMBL9700493 | 1.00 | EPHX2 (0.51) | EPHX2DNM1GPR84PPARGPPARD | |
| SCHEMBL14763563 | 1.00 | EPHX2 (0.51) | EPHX2DNM1GPR84PPARGPPARD | |
| SCHEMBL7273343 | 1.00 | EPHX2 (0.51) | EPHX2DNM1GPR84PPARGPPARD | |
| SCHEMBL28824246 | 1.00 | EPHX2 (0.51) | EPHX2DNM1GPR84PPARGPPARD | |
| SCHEMBL5395582 | 1.00 | EPHX2 (0.51) | EPHX2DNM1GPR84PPARGPPARD | |
| SCHEMBL11788859 | 0.98 | EPHX2 (0.50) | EPHX2DNM1GPR84PPARGPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3284792-B1 | METHOD FOR PREPARING CERAMIC INK COMPRISING METAL PRECURSOR AND CERAMIC PIGMENT AND CERAMIC INK MANUFACTURED BY THE SAME | INKTEC CO LTD (KR) | 2019-10-09 | — | — | EP | claimed |
| EP-2066497-B1 | MANUFACTURING METHODS FOR METAL CLAD LAMINATES | INKTEC CO LTD (KR) | 2018-11-07 | — | — | EP | claimed |
| EP-2013298-B1 | COMPOSITIONS FOR FORMING REFLECTING LAYER HAVING ORGANIC SILVER COMPLEXES,AND METHOD FOR PREPARING REFLECTING LAYER USING SAME | INKTEC CO LTD (KR) | 2018-06-27 | — | — | EP | claimed |
| EP-2003976-B1 | USE OF AN ANTIBACTERIAL COMPOSITION CONTAINING ORGANIC SILVER COMPLEXES | INKTEC CO LTD (KR) | 2016-12-21 | — | — | EP | claimed |
| EP-2052043-B1 | PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME | INKTEC CO LTD (KR) | 2016-10-12 | — | — | EP | claimed |
| EP-1846422-B1 | ORGANIC SILVER COMPLEXES, THEIR PREPARATION METHODS AND THEIR METHODS FOR FORMING THIN LAYERS | INKTEC CO LTD (KR) | 2016-04-13 | — | — | EP | claimed |
| EP-1853671-B1 | CONDUCTIVE INKS AND MANUFACTURING METHOD THEREOF | INKTEC CO LTD (KR) | 2013-07-31 | — | — | EP | claimed |
| US-11117889-B1 | IRAK degraders and uses thereof | KYMERA THERAPEUTICS, INC. (US) | 2021-09-14 | — | — | US | disclosed |
| EP-2052043-B1 | PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME | INKTEC CO LTD (KR) | 2016-10-12 | — | — | EP | disclosed |
| EP-2052043-A1 | PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME | Inktec Co., Ltd. (KR) | 2009-04-29 | — | — | EP | disclosed |
| WO-2008018718-A1 | PROCESS FOR PREPARATION OF SILVER NANOPARTICLES, AND THE COMPOSITIONS OF SILVER INK CONTAINING THE SAME | INKTEC CO., LTD. (KR) | 2008-02-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11117889-B1 | IRAK degraders and uses thereof | IRAK2, IRAK3, IRAK1 | EPHX2 1890/4885DNM1 4044/4885GPR84 1294/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.